Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Buyout before PH3 data

<< Previous

Bullboard Posts

Next >>

Comment by BudFoxx2020on Oct 03, 2023 10:38am

174 Views

Post# 35666746

RE:Buyout before PH3 data

Blind pumping aside. I believe it is LIGHTS OUT. ScienceFirst aka Bencro aka the great leader already took off after 20 years of non stop pumping and creating so many bag holders. This is always a glaring sign in a penny stock. The main promoters and the leader disappears. Then it is just a matter of time. Ofcouse just my 0.02 cents.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland